QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barlow, S. B. Articles by Cabral, F. Search for Related Content PubMed PubMed Citation Articles by Barlow, S. B. Articles by Cabral, F.

Paclitaxel-dependent mutants have severely reduced microtubule assembly and reduced tubulin synthesis

Steven B. Barlow^*, Manuel L. Gonzalez-Garay and Fernando Cabral

Department of Integrative Biology and Pharmacology, University of Texas Medical School, Houston, Texas 77225, USA
^* Present address: Department of Biology, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182-4614, USA
Present address: Lexicon Genetics Inc., 4000 Research Forest Drive, The Woodlands, TX 77381, USA

Author for correspondence (e-mail: fcabral{at}uth.tmc.edu)

Accepted 8 June 2002

A subset of mutant cell lines selected for resistance to the antitumor drug paclitaxel are unable to progress normally through mitosis unless the drug is present in the growth medium. Without paclitaxel the cells form defective spindles, undergo aberrant mitoses, fail to complete cell division and eventually die. Analysis of these drug-dependent cells revealed a low amount of microtubule polymer and less tubulin production than wild-type cells. Ribonuclease protection experiments indicated that the decreased tubulin protein was due to decreased tubulin mRNA. Enhancing microtubule assembly by treating the cells with paclitaxel, restored tubulin to levels comparable with those of paclitaxel-treated wild-type cells, which demonstrated that the drug-dependent cells do not have a permanent impairment in their capacity to synthesize tubulin. Paclitaxel-resistant (but not dependent) cells have a smaller reduction in microtubule polymer with little or no decrease in tubulin production, whereas colcemidresistant cells have increased microtubule assembly but also exhibit little or no change in tubulin production. Finally, a mutant cell line producing an unstable ß-tubulin protein has normal growth as well as normal synthesis and polymerization of tubulin, despite an approximately 30% decrease in steady state tubulin content. These studies establish a lower limit of tubulin assembly needed for cell survival and indicate that tubulin assembly must fall below this point to trigger a significant decrease in tubulin synthesis.

Key words: Paclitaxel resistance, Tubulin synthesis, Autoregulation

This article has been cited by other articles:

				M. E. Sellin, P. Holmfeldt, S. Stenmark, and M. Gullberg Global Regulation of the Interphase Microtubule System by Abundantly Expressed Op18/Stathmin Mol. Biol. Cell, July 1, 2008; 19(7): 2897 - 2906. [Abstract] [Full Text] [PDF]

				G. Cheng, M. R. Zile, M. Takahashi, C. F. Baicu, D. D. Bonnema, F. Cabral, D. R. Menick, and G. Cooper 4th A direct test of the hypothesis that increased microtubule network density contributes to contractile dysfunction of the hypertrophied heart Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2231 - H2241. [Abstract] [Full Text] [PDF]

				T. Fojo Commentary: Novel Therapies for Cancer: Why Dirty Might Be Better Oncologist, March 1, 2008; 13(3): 277 - 283. [Full Text] [PDF]

				J.-S. Kim, Y.-C. Lee, H.-T. Nam, G. Li, E.-J. Yun, K.-S. Song, K.-S. Seo, J.-H. Park, J.-W. Ahn, O. Zee, et al. Apicularen A Induces Cell Death through Fas Ligand Up-Regulation and Microtubule Disruption by Tubulin Down-Regulation in HM7 Human Colon Cancer Cells Clin. Cancer Res., November 1, 2007; 13(21): 6509 - 6517. [Abstract] [Full Text] [PDF]

				S. Yin, F. Cabral, and S. Veeraraghavan Amino acid substitutions at proline 220 of {beta}-tubulin confer resistance to paclitaxel and colcemid Mol. Cancer Ther., October 1, 2007; 6(10): 2798 - 2806. [Abstract] [Full Text] [PDF]

				H. Yang and F. Cabral Heightened Sensitivity to Paclitaxel in Class IVa beta-Tubulin-transfected Cells Is Lost as Expression Increases J. Biol. Chem., September 14, 2007; 282(37): 27058 - 27066. [Abstract] [Full Text] [PDF]

				Y. Wang, G. Tian, N. J. Cowan, and F. Cabral Mutations Affecting beta-Tubulin Folding and Degradation J. Biol. Chem., May 12, 2006; 281(19): 13628 - 13635. [Abstract] [Full Text] [PDF]

				K. Kamath, L. Wilson, F. Cabral, and M. A. Jordan {beta}III-Tubulin Induces Paclitaxel Resistance in Association with Reduced Effects on Microtubule Dynamic Instability J. Biol. Chem., April 1, 2005; 280(13): 12902 - 12907. [Abstract] [Full Text] [PDF]

				P. Fanara, S. Turner, R. Busch, S. Killion, M. Awada, H. Turner, A. Mahsut, K. L. LaPrade, J. M. Stark, and M. K. Hellerstein In Vivo Measurement of Microtubule Dynamics Using Stable Isotope Labeling with Heavy Water: EFFECT OF TAXANES J. Biol. Chem., November 26, 2004; 279(48): 49940 - 49947. [Abstract] [Full Text] [PDF]

				M. Hari, Y. Wang, S. Veeraraghavan, and F. Cabral Mutations in {alpha}- and {beta}-Tubulin That Stabilize Microtubules and Confer Resistance to Colcemid and Vinblastine Mol. Cancer Ther., July 1, 2002; 2(7): 597 - 605. [Abstract] [Full Text] [PDF]